Wary pharma: AstraZeneca sours on UK

警惕药企:阿斯利康对英国态度转冷

The Intelligence from The Economist

2025-09-18

22 分钟
PDF

单集简介 ...

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.  Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
更多

单集文稿 ...

  • The Economist.

  • Hello and welcome to The Intelligence from The Economist.

  • I'm Jason Palmer.

  • And I'm Rosie Bloor.

  • Every weekday we provide a fresh perspective on the events shaping your world.

  • Ukraine's war has shown how drones will play a bigger role in future conflicts.

  • Not just impromptu off-the-shelf stuff, though.

  • From an aircraft carrier deck, we look at the first signs of a hybrid air wing,

  • the future of manned, unmanned cooperation in the skies.

  • And in the Caribbean, successive hurricanes have battered the coral and devastated the barrier reef.

  • Our correspondent took a hardship gig to a tropical island,

  • where projects to restore the coral have had impressive results.

  • First up though.

  • Later today, Britain's Prime Minister Keir Starmer will meet Donald Trump to enjoy the priceless,

  • eternal and irreplaceable relationship as part of the American President's state visit.

  • Multi-billion dollar investments in the UK announced by Alphabet and Microsoft ahead of the trip will be welcomed cheer to the embattled Prime Minister.

  • And just yesterday,

  • Nvidia's boss Jensen Huang said he was there to declare that the country will become an AI superpower,

  • as he too took a £500 million stake in a British firm.

  • But here's the thing,